RUA: Revenue surged, losses narrowed, and a capital raise is planned to fund further growth

About this update from Rua Bioscience Ltd.

The meeting highlighted strong revenue growth, reduced losses, and expansion into five markets, while emphasizing the need for a NZD 2 million capital raise and the sale of a manufacturing facility to support ongoing operations. All resolutions were supported, and the board remains focused on cost control and strategic growth.Based on This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

View stock analysis, news, and events for Rua Bioscience Ltd.